At the heart of the Oncopole of Toulouse, the CRCT, together with all its partners (institutional, academic, clinical, industrial, charities…), stimulates innovation in terms of research and teaching in the fight against cancer.
The CRCT is a joint Research Unit Inserm & University Toulouse III Paul Sabatier
3 research teams are also labelled by the CNRS
Research teams
Platform facilities
Researchers, clinicians and supports
PhD students and post-doctoral fellows
News
Genetic polymorphisms involved in trabectedin-related liver toxicity.
Trabectedin is a cytotoxic drug used for the treatment of advanced soft tissue sarcoma. One of the most frequent side effects is hepatotoxicity, which occurs in nearly 40% of patients. In this pharmacogenetic study, we aimed to identify genetic polymorphisms that...
Cancer: a key mechanism of resistance to immunotherapy identified
An international team [1], led by Dr Ludovic Martinet (Inserm researcher) and Pr Hervé Avet-Loiseau from the Toulouse Cancer Research Centre (CRCT / Inserm, University of Toulouse III - Paul Sabatier, CNRS), has just published a study in the journal Immunity which...
Audrey Lumeau (team 10) awarded at “the 5th AEK Autumn School” of AEK 2020
This year, the German Cancer Society (AEK) is presenting "the 5th AEK Autumn School" on the theme of "replicative stress and cancer". This Autumn School aims to promote exchanges between young scientists and experienced researchers in the field. In addition to...
CRCT upcoming events
Calendar
Find us
Centre de Recherches en Cancérologie de Toulouse
2 avenue Hubert Curien
31037 TOULOUSE CEDEX 1 – FRANCE
Contact us
Tel : +33(0) 5 82 74 15 75
Fax : +33(0) 5 82 74 16 85
| Contact form
